Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Chiara Pighi, Taek-Chin Cheong, Mara Compagno, Enrico Patrucco, Maddalena Arigoni, Martina Olivero, Qi Wang, Cristina López, Stephan H. Bernhart, Bruno M. Grande, Teresa Poggio, Fernanda Langellotto, Lisa Bonello, Riccardo Dall’Olio, Sandra Martínez-Martín, Luca Molinaro, Paola Francia di Celle, Jonathan R. Whitfield, Laura Soucek, Claudia Voena, Raffaele Calogero, Ryan D. Morin, Louis M. Sta

Journal title: Blood Advances 2021

Journal number: (2021) 5 (23)

Journal publisher: ASH Publications

Published year: 2021

Published pages: 5239–5257

DOI identifier: 10.1182/bloodadvances.2021005682

ISSN: 2473-9537